PCVX

Vaxcyte Inc. Common Stock

HealthcareBiotechnologyUnited StatesNASDAQ

$56.93

+2.23%today

MKT CAP

$8.2B

-8.9% · 1Y

Full Financials

Trailing P/E-

Forward P/E-7.0x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership0.5%

Institutional Ownership104.0%

Short % of Float10.00%

Days to Cover10.7d

1 Week-6.5%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
NUVL Nuvalent Inc. Class A Common Stock	$8.2B	-	-	-	-	-41.2%	0%	-	0.00%
KRYS Krystal Biotech Inc. Common Stock	$8.4B	31	38.1	27.9	-	-	-	-	0.00%
HALO Halozyme Therapeutics Inc. Common Stock	$7.9B	73	25.5	6.6	-	-	-	-	0.00%
IBRX ImmunityBio Inc. Common Stock	$8.7B	5	-	-	-	-	-	-	0.00%
PRAX Praxis Precision Medicines Inc. Common Stock	$9.3B	5	-	-	-	-	-	-	0.00%
CYTK Cytokinetics Incorporated Common Stock	$9.3B	-	-	-	-	-	-	-	0.00%